EVENT

Boosting EU Competitiveness through Public-Private Partnerships in Rare Disease Research: the role of European Reference Networks

MEPs Stine Bosse (Renew Europe, Denmark) and András Kulja (EPP, Hungary) invite you to a high-level conference in the European Parliament, exploring how public-private partnerships in rare disease research can unlock new therapies and boost EU innovation and competitiveness.

Rare diseases affect over 30 million Europeans, yet they remain under-researched and underserved due to their complexity and low prevalence.

Public-private partnerships (PPPs) involving European Reference Networks (ERNs) and the pharmaceutical industry have emerged as powerful tools to accelerate rare disease research and innovation. By leveraging the expertise of ERNs, the capabilities of industry stakeholders, and the input of patient communities, these collaborations contribute not only to improved health outcomes but also to the European Union’s competitiveness in the global life sciences arena.

The event will explore how such partnerships address research gaps, enhance innovation capacity and support the EU’s strategic objectives, including fostering economic growth, scientific leadership, and patient-centric care.

Event details

When: 12:00-15:00, 24 September 2025

Where: European Parliament, Brussels (SPINELLI 5G1)

Meeting point: Station Europe, Espace Léopold, Place du Luxembourg, 1050 Brussels

Agenda

12:00 – Networking lunch for all guests
13:00 – Turning collaboration into impact for rare disease research and EU competitiveness

Introduction
Sheela Upadhyaya, Chair of Together For Rare Diseases
13:05 – Charting the path ahead through policy, partnerships and European leadership in rare Disease research

Keynote speech
MEP Stine Bosse, Vice-Chair of the SANT Committee
13:15 – Multistakeholder perspectives to unlock the potential of public-private partnerships in rare disease research and diagnosis on Europe’s emerging legislative framework

Panel discussion
TBA
14:50 – From dialogue to action: consolidating insights and advancing the EU agenda on rare diseases to boost our competitiveness

Concluding remarks
MEP András Kulja, Member of the SANT Committee

Sheela Upadhyaya, Chair of Together For Rare Diseases

Together4RD on Twitter

01 January at 12:00am